Calling all Speakers

The Biosimilars & Biologics Summit 2023 is seeking presentations that broadly focus on the following key topics:

• Emerging trends in developing biosimilars and biologic therapeutics
• The role of biosimilars design in the development of new drug modalities
• Exploring new technological advances for the enhanced production of biosimilars
• Latest research in bioavailability and bioequivalence assessment of biologic drugs
• Regulatory and IP strategies for new-to-market biosimilar-based therapeutics
• Case studies, clinical trials, and pharmacometrics analysis for biosimilars development

The Biosimilars & Biologics Summit 2023 offers a unique and timely focus on addressing the challenges associated with new technologies for biosimilar design and development for chronic disease management and novel drug modalities.

Be a part of our multi-disciplined agenda…

The Biosimilars & Biologics Summit 2023 will be an opportunity for professionals engaged in relevant disciplines to report on their accomplishments and exchange views. The event will have a unique emphasis on networking and building new relationships, including generating dialogue in technical know-how for the pharma and biotech industry. There will also be an opportunity to integrate with leading biotech and pharmaceutical companies and to demonstrate an insight into new technologies and techniques for chronic disease management and novel drug modalities.

Presentations focusing on new technologies, clinical trials, manufacturer case studies, and new market data for biosimilars are a focus for this conference along with other relevant topics of timely interest.

Please consider participating in what is certain to be a highly productive experience with an opportunity to collaborate with industry experts in this fast-evolving market.

Call for Presentation
If you would like to be a speaker at this event, please contact sean.collins@iQ-Hub.com, subject heading “Call for Papers – Biosimilars & Biologics Summit 2023”.